Clinical Trial Update: Study of Nivolumab (BMS-936558) in Combination With Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Carboplatin/Paclitaxel, Bevacizumab Maintenance, Erlotinib, Ipilimumab or as Monotherapy in Subjects With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC) (CheckMate 012) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating nivolumab in combination with various chemotherapies or as monotherapy for advanced non-small cell lung cancer; trial completed with po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Non-small Cell Lung Cancer | Phase 1 | Status: COMPLETED | Results posted: 2019-08-05